MedPath

Comparative Study of Robotic, Laparoscopic and Open Surgery for Enucleation of Benign Pancreatic Neoplasms

Not Applicable
Completed
Conditions
Pancreatic Neuroendocrine Tumors
Interventions
Procedure: Laparoscopic surgery
Procedure: Robotic surgery
Procedure: Open surgery
Registration Number
NCT02125929
Lead Sponsor
Peking Union Medical College Hospital
Brief Summary

To determine the efficacy and safety of robotic, laparoscopic and open surgery for enucleation of benign pancreatic neuroendocrine tumors

Detailed Description

The study was prospective and retrospective, non-randomized study included patients with benign pancreatic neoplasms. The robotic arm consecutively includes patients underwent robotic enucleation surgery and expected number in this arm is 50. The laparoscopic and open surgery arms retrospectively include case from the year 2004. The number of patients for laparoscopic and open surgery arms are 50 and 100, respectively.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
156
Inclusion Criteria
  • 18-80 years old
  • Body Mass Index<30
  • Preoperative diagnosis of resectable benign Pancreatic Neuroendocrine Tumors
  • Tumor type: Non-functional pancreatic endocrine tumours and insulinomas
  • largest diameter < 4cm
  • Preoperative CT showed no evidence that tumor was connected with main pancreatic duct
Exclusion Criteria
  • Severe cardio/pulmonary complications
  • Other pancreatic diseases, including pancreatitis and pancreatic cancer
  • Multiple pancreatic neuroendocrine tumors
  • Distant metastasis

Study & Design

Study Type
INTERVENTIONAL
Study Design
FACTORIAL
Arm && Interventions
GroupInterventionDescription
Laparoscopic surgeryLaparoscopic surgerylaparoscopic surgery for enucleation benign Pancreatic Neuroendocrine Tumors Case number = 50
robotic armRobotic surgeryrobotic surgery for enucleation benign Pancreatic Neuroendocrine Tumors Case number = 50
Open surgeryOpen surgeryOpen surgery for enucleation benign Pancreatic Neuroendocrine Tumors Case number = 100
Primary Outcome Measures
NameTimeMethod
Pancreatic fistula rateup to 30 days
Secondary Outcome Measures
NameTimeMethod
Mortality rateup to 30 days

Trial Locations

Locations (1)

Department of General Surgery, Peking Union medical school hospital

🇨🇳

Beijing, Beijing, China

© Copyright 2025. All Rights Reserved by MedPath